## Core Concept
Juvenile Myoclonic Epilepsy (JME) is a common form of generalized epilepsy that typically presents in adolescence. It is characterized by myoclonic seizures, generalized tonic-clonic seizures, and sometimes absence seizures. The management of JME involves antiepileptic drugs that are effective against generalized seizures.

## Why the Correct Answer is Right
Valproate, levetiracetam, and lamotrigine are commonly used in the treatment of JME due to their efficacy against generalized seizures, including myoclonic, tonic-clonic, and absence seizures. On the other hand, **oxcarbazepine** is primarily used for partial seizures and some forms of generalized seizures but is not a first-line treatment for JME. It can sometimes worsen myoclonic seizures.

## Why Each Wrong Option is Incorrect
* **Option A: Valproate** is incorrect because it is actually a first-line treatment for JME, effective against all seizure types seen in JME.
* **Option B: Levetiracetam** is incorrect because it is also used in the treatment of JME, providing broad-spectrum efficacy.
* **Option C: Lamotrigine** is incorrect as it is another drug used in JME, particularly effective for absence seizures and myoclonic seizures.

## Clinical Pearl / High-Yield Fact
A key point to remember is that in JME, **valproate** is often considered a first-line treatment due to its broad efficacy, but **lamotrigine** and **levetiracetam** are also commonly used alternatives, especially in women of childbearing potential due to valproate's teratogenic effects.

## Correct Answer: D. Oxcarbazepine